ambodryl,
bromazine,
bromodiphenhydramine,
bromodiphenhydramine hydrochloride,
Bromazine hydrochloride,
1808-12-4,
Ambodryl hydrochloride,
Bromdiphenhydramine hydrochloride,
Bromodiphenhydramine hydrochloride,
Bromdiphenylhydramine hydrochloride,
Ambodryl,
Bromodiphenhydramine HCl,
NSC 36113,
Bromo-Benzdryl,
EINECS 217-310-9,
Bromodiphenhydramine hydrochloride [USP],
4-Bromo-alpha-phenylbenzyl 2-dimethylaminoethyl ether,
CHEBI:59178,
2-(4-Bromobenzohydryloxy)-ethyl-dimethylamine hydrochloride,
4-Bromodiphenhydramine hydrochloride,
2-((4-Bromophenyl)(phenyl)methoxy)-N,N-dimethylethanamine hydrochloride,
2-((p-Bromo-alpha-phenylbenzyl)oxy)-N,N-dimethylethylamine hydrochloride,
Ethanamine, 2-((4-bromophenyl)phenylmethoxy)-N,N-dimethyl-, hydrochloride,
2-[(4-bromophenyl)-phenylmethoxy]-N,N-dimethylethanamine;hydrochloride,
2-((4-Bromophenyl)phenylmethoxy)ethyl(dimethyl)ammonium chloride,
Ethanamine, 2-((4-bromophenyl)phenylmethoxy)-N,N-dimethyl-, hydrochoride,
AC1LASIH,
ETHYLAMINE, 2-((p-BROMO-alpha-PHENYLBENZYL)OXY)-N,N-DIMETHYL-, HYDROCHLORIDE,
SCHEMBL141831,
CHEMBL1200967,
BCP27786,
NSC36113,
NSC-36113,
WLN: ER DYR&O2N1&1 &GH,
AKOS027382254,
API0008908,
2-(4-Bromodiphenylmethoxy)ethyldimethylamine,
FT-0663610,
4-Bromo-.alpha.-phenylbenzyl 2-dimethylaminoethyl ether,
Diphenhydramine Impurity C HCl (Bromazine Hydrochloride),
2-(4-Bromodiphenylmethoxy)ethyldimethylamine Hydrochloride,
2-[(4-Bromobenzohydryl)oxy]ethyldimethylamine hydrochloride,
4-Bromo-.alpha.-phenylbenzyl 2-(dimethylamino)ethyl ether,
.beta.-(p-Bromobenzhydryloxy)ethyldimethylamine hydrochloride,
.beta.-[(p-Bromobenzhydryl)oxy]ethyldimethylamine hydrochloride,
2-(p-Bromobenzhydryloxy)-N,N-dimethylethylamine hydrochloride,
Bromazine Hydrochloride 1.0 mg/ml in Methanol (as free base),
2-[(4-bromophenyl)-phenylmethoxy]-N,N-dimethylethanamine hydrochloride,
2-[(4-Bromophenyl)phenylmethoxy]-N,N-dimethylethanamine Hydrochloride,
2-[(p-Bromo-|A-phenylbenzyl)oxy]-N,N-dimethylethylamine Hydrochloride,
Bromodiphenhydramine hydrochloride, United States Pharmacopeia (USP) Reference Standard,
Ethanamine, 2-((4-bromophenyl)phenylmethoxy)-N,N-dimethyl-, hydrochloride (9CI),
2-[(RS)-(4-BROMOPHENYL) PHENYLMETHOXY]-N,NDIMETHYLETHANAMINE HYDROCHLORIDE (Bromodiphenhydramine Hydrochloride) (Diphenhydramine Impurity C), Pharmaceutical Secondary Standard; Certified Reference Material,
2-[(RS)-(4-Bromophenyl)phenylmethoxy]-N,N-dimethylethanamine hydrochloride, pharmaceutical impurity standard,
Bromazin,
Bromazine,
Deserol,
bromodiphenhydramine,
C17H20BrNO.ClH,
UNII-202J683U97,
C17-H20-Br-N-O.Cl-H,
CID519514,
Ethanamine,N-dimethyl-, hydrochloride,
Ethylamine,N-dimethyl-, hydrochloride,
202J683U97,
beta-(p-Bromobenzhydryloxy)ethyldimethylamine hydrochloride,
BROMODIPHENHYDRAMINE HYDROCHLORIDE (200 MG),
|A-(p-Bromobenzhydryloxy)ethyldimethylamine Hydrochloride,
2-[(4-bromophenyl)phenylmethoxy]ethyl(dimethyl)ammonium chloride,
Ethanamine, 2-[(4-bromophenyl)phenylmethoxy]-N,N-dimethyl-, hydrochloride,
Ethylamine, 2-[(p-bromo-.alpha.-phenylbenzyl)oxy]-N,N-dimethyl-, hydrochloride,